Short-term effect analysis of radiofrequency ablation combined chemotherapy on middle and late period non-small cell lung cancer

Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI

Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H and Jablons DM: Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 132:193–199. 2007. View Article : Google Scholar : PubMed/NCBI

Liu B, Liu L, Li Y, Wang H, Hu M, Qian K, Wang R and Zhi X: Survival after radiofrequency ablation for 100 cases of lung neoplasms. Zhongguo Fei Ai Za Zhi. 14:335–339. 2011.(In Chinese). PubMed/NCBI

Oshima F, Yamakado K, Akeboshi M, Takaki H, Nakatsuka A, Makita M and Takeda K: Lung radiofrequency ablation with and without bronchial occlusion: experimental study in porcine lungs. J Vasc Interv Radiol. 15:1451–1456. 2004. View Article : Google Scholar : PubMed/NCBI

Zhao J, Wu Y, Wang Y, et al: Treatment of local late period NSCLC by RFA combined chemoradiotherapy. Cancer Res Prev Treat. 8:495–497. 2004.

Iguchi T, Hiraki T, Gobara H, Mimura H, Fujiwara H, Tajiri N, Sakurai J, Yasui K, Date H and Kanazawa S: Percutaneous radiofrequency ablation of lung tumors close to the heart or aorta: evaluation of safety and effectiveness. J Vasc Interv Radiol. 18:733–740. 2007. View Article : Google Scholar : PubMed/NCBI

Qian K, Zhang Y, Zhi XY, Liu BD, Su L, Li Y and Wang H: Study on the safety of radiofrequency ablation in patients with lung cancer above 70 years old. Chinese J Clinicians (Electronic Edition). 7:5332–5334. 2013.(In Chinese).

Grossi F, Aita M, Defferrari C, Rosetti F, Brianti A, Fasola G, Vinante O, Pronzato P and Pappagallo G: Impact of third- generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach. Oncologist. 14:497–510. 2009. View Article : Google Scholar : PubMed/NCBI

Goldberg SN, Gazelle GS and Mueller PR: Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol. 174:323–331. 2000. View Article : Google Scholar : PubMed/NCBI

Liu B, Zhi X, Liu L, Hu M, Wang R, Xu Q, Zhang Y and Su L: Evaluation of three-dimensional reconstruction CT in percutaneous radiofrequency ablation (RFA) of the unresectable lung tumor with a clustered electrode. Zhongguo Fei Ai Za Zhi. 12:775–779. 2009.(In Chinese). PubMed/NCBI

Anderson EM, Lees WR and Gillams AR: Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol. 32:478–483. 2009. View Article : Google Scholar : PubMed/NCBI

Higaki F, Okumura Y, Sato S, Hiraki T, Gobara H, Mimura H, Akaki S, Tsuda T and Kanazawa S: Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor. Ann Nucl Med. 22:157–163. 2008. View Article : Google Scholar : PubMed/NCBI

Wang J, Wang Y and Zhao J: Short-term and long-term effect of RFA on local late period NSCLC. Int Med Health Guidance News. 12:20–23. 2006.(In Chinese).

Mohamed Lotayef, Azza Taher, Hanna Attia, Azza Nasr, El Hossieny Hisham, Mohammed Mahmoud and Noha Essam: A clinic-epidemilogical study of cases of locally advanced non small cell lung cancer (NSCLC) that received radiotherapy at NCI Cairo in the period from 2001–2010. J Cancer Ther. 5:542–551. 2014. View Article : Google Scholar